Literature DB >> 8840820

Quality of life research and health technology assessment--a time for synergy.

R N Battista1, M J Hodge.   

Abstract

Measuring quality of life and assessing technologies are both increasingly prominent in health care systems. This growth has accompanied growing concern over aging populations and health care expenditure growth. Nevertheless, there appears to be unrealized potential for synergy between quality of life research and technology assessment. In this paper, we consider the roles and challenges facing quality of life research in three domains: research-particularly clinical trials of therapeutics; clinical situations and policy-making. We then examine the potential for synergy in these domains and conclude that expanding collaboration will strengthen both fields and intensify their impact in research, clinical practice and policy-making.

Mesh:

Year:  1996        PMID: 8840820     DOI: 10.1007/bf00449915

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  13 in total

1.  Using health status measures in the hospital setting: from acute care to 'outcomes management'.

Authors:  D Lansky; J B Butler; F T Waller
Journal:  Med Care       Date:  1992-05       Impact factor: 2.983

Review 2.  Lessons from the eight countries.

Authors:  R N Battista; H D Banta; E Jonnson; M Hodge; H Gelband
Journal:  Health Policy       Date:  1994 Oct-Dec       Impact factor: 2.980

Review 3.  Health care technology in Canada (with special reference to Quebec).

Authors:  R N Battista; R Jacob; M J Hodge
Journal:  Health Policy       Date:  1994 Oct-Dec       Impact factor: 2.980

Review 4.  The status of health assessment 1994.

Authors:  J E Ware
Journal:  Annu Rev Public Health       Date:  1995       Impact factor: 21.981

Review 5.  Medicine, practice and guidelines: the uneasy juncture of science and art.

Authors:  R N Battista; M J Hodge; P Vineis
Journal:  J Clin Epidemiol       Date:  1995-07       Impact factor: 6.437

6.  The escalating number of uninsured in the United States.

Authors:  L Summer
Journal:  Int J Health Serv       Date:  1994       Impact factor: 1.663

7.  Health-care reform: the issues and the role of donors.

Authors:  S Foster; C Normand; R Sheaff
Journal:  Lancet       Date:  1994-07-16       Impact factor: 79.321

8.  Food and Drug Administration requirements for approval of new anticancer drugs.

Authors:  J R Johnson; R Temple
Journal:  Cancer Treat Rep       Date:  1985-10

9.  The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada.

Authors:  S Sheingold; D Churchill; N Muirhead; A Laupacis; R Labelle; R Goeree
Journal:  Soc Sci Med       Date:  1992-05       Impact factor: 4.634

Review 10.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

View more
  4 in total

1.  A gap approach to exploring quality of life in mental health.

Authors:  J Welham; M Haire; D Mercer; T Stedman
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  Assessing the quality of life of adults with chronic respiratory diseases in routine primary care: construction and first validation of the 10-Item Respiratory Illness Questionnaire-monitoring 10 (RIQ-MON10).

Authors:  J E Jacobs; A R Maillé; R P Akkermans; C van Weel; R P T M Grol
Journal:  Qual Life Res       Date:  2004-08       Impact factor: 4.147

3.  Health-related quality of life and utility scores in people with mental disorders: a comparison with the non-mentally ill general population.

Authors:  Amélie Prigent; Ane Auraaen; Blaise Kamendje-Tchokobou; Isabelle Durand-Zaleski; Karine Chevreul
Journal:  Int J Environ Res Public Health       Date:  2014-03-07       Impact factor: 3.390

Review 4.  Quality of life assessment and reporting in randomized controlled trials: a study of literature published from Japan.

Authors:  Mariko Naito; Takeo Nakayama; Shunichi Fukuhara
Journal:  Health Qual Life Outcomes       Date:  2004-06-25       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.